03:44 PM EST - Lorus Therapeutics Inc. : reported a full-year 2009 net loss of $8.9 million or $0.04 per share, compared to a net loss of $6.3 million or $0.03 per share in the previous year. Revenue for the year was $184,000, up from $43,000 in the last year. Lorus Therapeutics Inc.
shares T.LOR are trading even at $0.08.
